Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1549230 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,066,811
+$2,477,379 QoQ
Shares Held
6,174
+367.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#572
of 1,735 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Sep 30, 2024
CallValue
$14,231,448
CallShares
30,600
PutValue
$14,231,448
PutShares
30,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. VRTX ranks #50 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,066,811 6,174
2026-03-31 $589,432 1,320
2025-09-30 $239,292 611
2025-06-30 $235,956 530
2025-03-31 $327,738 676
2024-09-30 $14,231,448 30,600
2024-09-30 $14,231,448 30,600
2022-06-30 $1,499,968 5,323
2022-03-31 $821,533 3,148
2021-12-31 $2,947,251 13,421
2021-09-30 $2,319,252 12,786
2021-06-30 $2,854,475 14,157
2021-03-31 $2,029,850 9,446
2020-12-31 $1,473,107 6,233